当功能恶化时,如何使用关键的心血管药物?
Karin Bergen1,2,3, Jonas Spaak1,3,4
1Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Clinical kidney journal
|January 14, 2026
概括
针对心血管疾病的指导指导医学疗法 (GDMT) 在晚期慢性病 (CKD) 中未得到充分利用. 本综述考察了GDMT在CKD4-5阶段的益处和风险,重点是心力衰竭管理.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 患有晚期心血管代谢综合征的患者心血管并发症风险较高.
- 指南导向医学疗法 (GDMT) 对于降低风险至关重要,但在晚期慢性病 (CKD) 试验中经常被排除在外.
- 这导致GDMT在CKD4-5阶段的不足利用,因为人们担心副作用,如高血和肌素增加.
研究的目的:
- 审查关于心血管药物使用在晚期CKD的证据.
- 强调GDMT治疗心力衰竭的CKD患者.
- 概述一个综合的心脏-脏病-糖尿病诊所治疗方法.
主要方法:
- 累积证据的临床审查.
- 在心力衰竭患者中强调GDMT的重点,CKD阶段为4-5.
- 在综合诊所环境中讨论治疗方法.
主要成果:
- 关于心血管药物在晚期CKD中所带来的益处和风险的证据往往不清楚.
- 由于临床惯性和对副作用的恐惧,GDMT的使用不足是常见的.
- 个性化治疗,临床判断和共享决策至关重要.
结论:
- 在晚期CKD中优化GDMT需要仔细考虑患者特定的因素.
- 治疗目标必须与患者的偏好保持一致,并适应越来越脆弱的情况.
- 综合护理模式对于管理复杂的心血管和脏疾病至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
207
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
207
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Renal Failure: Dose Adjustments
434
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
434
Chronic Kidney Disease IV: Nursing Management
314
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
314
Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215


